Scope of Responsibilities The Senior Drug Safety Associate Sr DSA will be responsible for the review evaluation and management of adverse event reports from studies of FibroGen products roxadustat and pamrevlumab in accordance with FDA EMEA China FDA other applicable health authorities and ICH guidelines and regulations The Sr DSA will act as the primary Drug Safety representative for assigned study project teams The DSA will report to the Safety Manager Director Senior Director of Drug Safety S

contact seller Read More

Copyright © 2018, All Rights Reserved.
Designated trademarks and brands are the property of their respective owners.